The partial dopamine agonist pardoprunox (SLV308) administered in combination with l-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets-Reference-Cited by-同舟云学术

The partial dopamine agonist pardoprunox (SLV308) administered in combination with l-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets

Published:2010-12 Issue:2 Volume:226 Page:320-327
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Tayarani-Binazir K.,Jackson M.J.,Rose S.,McCreary A.C.,Jenner P.

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference31 articles.

1. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature;Ahlskog;Mov. Disord.,2001

2. Pergolide in the treatment of patients with early and advanced Parkinson's disease;Bonuccelli;Clin. Neuropharmacol.,2002

3. Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980;Bravi;Mov. Disord.,1993

4. Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease;Bronzova;Mov. Disord.,2010

5. The partial dopamine receptor agonist terguride in the MPTP-induced hemiparkinsonian monkey model;Brucke;Eur. J. Pharmacol.,1988

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders;Current Drug Targets;2022-07

2. Synthesis and Biological Evaluation of a Series of Novel 1-(3-((6-Fluoropyridin-3-yl)oxy)propyl)piperazines as Dopamine/Serotonin Receptor Agonists;Pharmaceutical Fronts;2022-03

3. The MPTP-lesioned marmoset model of Parkinson’s disease: proposed efficacy thresholds that may potentially predict successful clinical trial results;Journal of Neural Transmission;2020-08-29

4. In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease;Current Neuropharmacology;2018-06-08

5. Predictive Value of Parkinsonian Primates in Pharmacologic Studies: A Comparison between the Macaque, Marmoset, and Squirrel Monkey;Journal of Pharmacology and Experimental Therapeutics;2018-03-09